| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA5187002
Max Phase: Preclinical
Molecular Formula: C21H15FN2OS
Molecular Weight: 362.43
Associated Items:
Representations
Canonical SMILES: CSc1ccc(C2C(C#N)=C(N)Oc3c2ccc2ccccc32)cc1F
Standard InChI: InChI=1S/C21H15FN2OS/c1-26-18-9-7-13(10-17(18)22)19-15-8-6-12-4-2-3-5-14(12)20(15)25-21(24)16(19)11-23/h2-10,19H,24H2,1H3
Standard InChI Key: XJMQALOATOUFRV-UHFFFAOYSA-N
Associated Targets(Human)
Transcriptional activator Myb 26 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 362.43 | Molecular Weight (Monoisotopic): 362.0889 | AlogP: 4.92 | #Rotatable Bonds: 2 |
| Polar Surface Area: 59.04 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
| #RO5 Violations: 0 | HBA (Lipinski): 3 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: | CX Basic pKa: 1.68 | CX LogP: 4.79 | CX LogD: 4.79 |
| Aromatic Rings: 3 | Heavy Atoms: 26 | QED Weighted: 0.66 | Np Likeness Score: -1.25 |
References
| 1. Köhler LHF, Reich S, Yusenko M, Klempnauer KH, Shaikh AH, Ahmed K, Begemann G, Schobert R, Biersack B.. (2022) A New Naphthopyran Derivative Combines c-Myb Inhibition, Microtubule-Targeting Effects, and Antiangiogenic Properties., 13 (11.0): [PMID:36385941] [10.1021/acsmedchemlett.2c00403] |
Source
Source(1):